| Oc Progressive Recovery Inc | |
|
1100 W Stewart Dr Er Department Orange CA 92868-3849 | |
| (714) 633-9111 | |
| Not Available |
| Full Name | Oc Progressive Recovery Inc |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 1100 W Stewart Dr, Orange, California |
| Authorized Official Name and Position | Ernest Rasyidi (CEO) |
| Authorized Official Contact | 9497151272 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Oc Progressive Recovery Inc 1 City Blvd W Suite 1100 Orange CA 92868-3621 Ph: (714) 571-5000 | Oc Progressive Recovery Inc 1100 W Stewart Dr Er Department Orange CA 92868-3849 Ph: (714) 633-9111 |
| NPI Number | 1003340217 |
|---|---|
| Provider Enumeration Date | 04/13/2017 |
| Last Update Date | 07/21/2022 |
| Medicare PECOS PAC ID | 7214207190 |
|---|---|
| Medicare Enrollment ID | O20170726000348 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003340217 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | (* (Not Available)) | Primary |
| Provider Name | Doris L Asombrado |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1992778666 PECOS PAC ID: 8628193513 Enrollment ID: I20100915000996 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Ashraf Ismail |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1720211691 PECOS PAC ID: 2264696749 Enrollment ID: I20120613000324 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Ernest Rasyidi |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1962644997 PECOS PAC ID: 7113182080 Enrollment ID: I20120626000663 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Veronica Y Kang |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1801815998 PECOS PAC ID: 2062667991 Enrollment ID: I20130227000059 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Samantha J Perkins |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790023281 PECOS PAC ID: 5890929236 Enrollment ID: I20150831000820 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Cindy B Illescas |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1720449358 PECOS PAC ID: 8224335971 Enrollment ID: I20160324001024 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Lina Irena Augius |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1205026705 PECOS PAC ID: 9133413784 Enrollment ID: I20160804002356 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Taqialdeen Zamil |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598154478 PECOS PAC ID: 8921389099 Enrollment ID: I20170103001574 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Shadi Aramesh |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1326487091 PECOS PAC ID: 6305105024 Enrollment ID: I20181114002894 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Pamela M Chumpitaz |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528424173 PECOS PAC ID: 5496088759 Enrollment ID: I20190531001924 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Cassandra Silver |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1508347485 PECOS PAC ID: 6103251525 Enrollment ID: I20200113002331 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Narmin Md Aliji |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1811288822 PECOS PAC ID: 8022448141 Enrollment ID: I20200413003655 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Christine Taheran |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144642109 PECOS PAC ID: 4486084084 Enrollment ID: I20200422002771 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Liezl Gatchalian Talamayan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1679127518 PECOS PAC ID: 7517375074 Enrollment ID: I20210421002372 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Diem-chau L Nguyen |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1891221404 PECOS PAC ID: 5597174409 Enrollment ID: I20210505002678 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Goli N Shenasan |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1669933925 PECOS PAC ID: 4183958739 Enrollment ID: I20210518003009 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Rohit Sanjeev Aiyer |
|---|---|
| Provider Type | Practitioner - Interventional Pain Management |
| Provider Identifiers | NPI Number: 1801207014 PECOS PAC ID: 2466787031 Enrollment ID: I20220810003565 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Abiodun Toriola |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235862780 PECOS PAC ID: 5698158244 Enrollment ID: I20220816000357 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Richard Angelo Monforte |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1487303475 PECOS PAC ID: 5799154183 Enrollment ID: I20221206003270 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Mariam Fazil |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235827429 PECOS PAC ID: 5597125849 Enrollment ID: I20230718002080 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Hieu Dinh Tran |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477263986 PECOS PAC ID: 9830550409 Enrollment ID: I20230728001890 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Andrea Yvette Meza |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1891213914 PECOS PAC ID: 0840651436 Enrollment ID: I20230728002923 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Pavel Ksendz |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790406882 PECOS PAC ID: 6901268739 Enrollment ID: I20230810003847 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Laura Perez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1972283869 PECOS PAC ID: 4183078132 Enrollment ID: I20230926001626 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Toni Rose Mallari Dela Paz |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1588356414 PECOS PAC ID: 4385099530 Enrollment ID: I20231009002459 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Andrew Dang |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1063192953 PECOS PAC ID: 9234584186 Enrollment ID: I20231012000563 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
| Provider Name | Ngoc Pham |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1366144180 PECOS PAC ID: 4284080599 Enrollment ID: I20231023002849 |
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
News Archive
ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.
Fitness trackers, smart watches, and other wearable technology are the number one fitness trend for 2019, according to an annual survey of health and fitness professionals published in the November issue of ACSM's Health & Fitness Journal, an official journal of the American College of Sports Medicine.
Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.
› Verified 4 days ago
Healing Space Therapy, Licensed Clinical Social Worker Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2230 W Chapman Ave Ste 207, Orange, CA 92868 Phone: 562-285-3509 | |
Neurovana Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2230 W Chapman Ave Ste 209, Orange, CA 92868 Phone: 714-696-8835 | |
Amhs Cat Orange Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4000 W Metropolitan Dr Ste 401, Orange, CA 92868 Phone: 866-830-6011 Fax: 714-954-2986 | |
K Himasiri De Silva Md Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 810 W La Veta Avenue, Orange, CA 92868 Phone: 714-532-6811 Fax: 714-532-5487 | |
Canyon Acres Children And Family Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1845 W Orangewood Ave, Suite 304, Orange, CA 92868 Phone: 714-393-9400 | |
Premier Behavioral Health Center, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 600 City Pkwy W Ste 400, Orange, CA 92868 Phone: 714-908-5645 Fax: 714-908-7257 |